Study on the expression levels of antibodies against SARS-CoV-2 at different period of disease and its related factors in 192 cases of COVID-19 patients
View ORCID ProfileJingyi Ou, View ORCID ProfileMingkai Tan, Haolan He, Haiyan Tan, Jiewen Mai, Yaoxiang Long, Xiaowen Jiang, Qing He, Ying Huang, Yan Li, Renshen Chen, Liya Li, View ORCID ProfileYaling Shi, Fang Li
doi: https://doi.org/10.1101/2020.05.22.20102525
Jingyi Ou
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Mingkai Tan
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Haolan He
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Haiyan Tan
2Department of Laboratory Medicine, Guangzhou Baiyun District Maternal and Child Health Hospital, Guangzhou, China.
Jiewen Mai
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Yaoxiang Long
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Xiaowen Jiang
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Qing He
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Ying Huang
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Yan Li
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Renshen Chen
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Liya Li
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Yaling Shi
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Fang Li
1Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Posted May 26, 2020.
Study on the expression levels of antibodies against SARS-CoV-2 at different period of disease and its related factors in 192 cases of COVID-19 patients
Jingyi Ou, Mingkai Tan, Haolan He, Haiyan Tan, Jiewen Mai, Yaoxiang Long, Xiaowen Jiang, Qing He, Ying Huang, Yan Li, Renshen Chen, Liya Li, Yaling Shi, Fang Li
medRxiv 2020.05.22.20102525; doi: https://doi.org/10.1101/2020.05.22.20102525
Study on the expression levels of antibodies against SARS-CoV-2 at different period of disease and its related factors in 192 cases of COVID-19 patients
Jingyi Ou, Mingkai Tan, Haolan He, Haiyan Tan, Jiewen Mai, Yaoxiang Long, Xiaowen Jiang, Qing He, Ying Huang, Yan Li, Renshen Chen, Liya Li, Yaling Shi, Fang Li
medRxiv 2020.05.22.20102525; doi: https://doi.org/10.1101/2020.05.22.20102525
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)